Endpoint Metric Analysis Endpoint Analysis, LLC
Your own data may help create economic advantages traditional stakeholder and competitors
What We Do
We help innovative medtech companies navigate the complex landscape of health economics and reimbursement, turning internal data into actionable insights that drive adoption and market access.
Health Economics & Microcosting
We use internal data sources to create tailored economic models—providing detailed insights that go beyond traditional modeling and support early-stage development through to commercialization.
Reimbursement Strategy
From coverage to coding to payment, we assess the full reimbursement landscape. We support CPT, HCPCS, and ICD-10 coding, Medicare and private insurer payment systems, and applications like NTAP and New Technology APC.
Education & Training
We develop customized training programs and webinars to equip stakeholders with the knowledge they need around reimbursement pathways, coding and compliance, and economic impact.
Empowering Smarter Market Access Decisions
Our economic analysis helps your team uncover real-world costs, reimbursement pathways, and market potential for medical technologies.
We turn internal data into actionable insights—equipping you with the tools to make confidentdecisions for clinical trials, regulatory submissions, and product launches.
Evidence-based and objective
Strategically aligned with your business goals
Delivered on schedule and tailored to your needs
Why It Matters
Early analysis prevents costly missteps
Internal data ensures accuracy over assumptions
Supports pricing, billing, and reimbursement strategy
Transparent, flat-fee pricing—no surprises
Trusted by Industry Leaders
Partnered with C-suite leaders, economists, and market access teams across the medtech space.
Protect your investment. Own your data.
“In a major matter no details are small.” – Jean-François de Gondi
Why Choose Us
We provide comprehensive reimbursement assessments, including coding, coverage, and payment strategies for both inpatient and outpatient settings. Our team supports microeconomic studies during clinical trials and commercialization phases, offering detailed comparisons to traditional procedures. Additionally, we assist with CMS Investigational Device Exemption (IDE) applications and offer guidance on clinical trial reimbursement to ensure optimal market access.